InflaRx N.V. Files 6-K for Registration Statement Incorporation
Ticker: IFRX · Form: 6-K · Filed: May 7, 2025 · CIK: 1708688
Sentiment: neutral
Topics: procedural, registration-statement, sec-filing
Related Tickers: INFX
TL;DR
INFX files 6-K to update registration statements, nothing new but procedural.
AI Summary
InflaRx N.V. filed a Form 6-K on May 7, 2025, to incorporate by reference Exhibits 99.1 and 99.2 into its existing registration statements on Form S-8 (File Nos. 333-221656 and 333-240185) and Form F-3 (File No. 333-273058). This filing pertains to the month of May 2025 and is a report of a foreign private issuer.
Why It Matters
This filing is procedural, incorporating previous exhibits into active registration statements, which is necessary for ongoing securities offerings or employee stock plans.
Risk Assessment
Risk Level: low — The filing is a routine procedural update and does not contain new financial information or material business developments.
Key Numbers
- 001-38283 — SEC File Number (Identifies InflaRx N.V.'s filings with the SEC.)
- May 2025 — Reporting Period (The month for which this Form 6-K report is filed.)
Key Players & Entities
- InflaRx N.V. (company) — Filer of the 6-K report
- 001-38283 (company) — SEC file number for InflaRx N.V.
- 333-221656 (company) — Form S-8 registration statement file number
- 333-240185 (company) — Form S-8 registration statement file number
- 333-273058 (company) — Form F-3 registration statement file number
FAQ
What is the purpose of this Form 6-K filing by InflaRx N.V.?
The purpose is to incorporate by reference Exhibits 99.1 and 99.2 into InflaRx N.V.'s existing registration statements on Form S-8 and Form F-3.
Which registration statements are being updated by this filing?
The filing updates registration statements on Form S-8 (File Nos. 333-221656 and 333-240185) and Form F-3 (File No. 333-273058).
What is the filing date of this Form 6-K?
The filing date is May 7, 2025.
Is InflaRx N.V. required to file annual reports on Form 20-F or 40-F?
Yes, InflaRx N.V. indicates it files annual reports under cover of Form 20-F.
What type of company is InflaRx N.V. according to this filing?
InflaRx N.V. is identified as a foreign private issuer in the pharmaceutical preparations industry.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 7, 2025 regarding InflaRx N.V. (IFRX).